Evidence map›Paper›PMID 25757405›Full record

ArticleJournal of clinical monitoring and computing2016

Performance of an active inspired hypoxic guard.

Idris E Ghijselings, Sofie De Cooman, Rik Carette, Philip J Peyton, Andre M De Wolf, Jan F A Hendrickx

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of clinical monitoring and computing, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. FLOW-i ventilator performance in the presence of a circle system leak.Journal of clinical monitoring and computing · 2017
    Article
  3. Review
  4. Letter to the Editor.Journal of clinical monitoring and computing · 2016
    Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Idris E GhijselingsDepartment of Anesthesiology, Intensive Care and Pain Therapy, OLV Hospital, Aalst, Belgium.
Sofie De CoomanDepartment of Anesthesiology, Sint-Jan Clinic, Brussels, Belgium.
Rik CaretteDepartment of Anesthesiology, Intensive Care and Pain Therapy, OLV Hospital, Aalst, Belgium.
Philip J PeytonDepartment of Anesthesia, Austin Hospital and University of Melbourne, Melbourne, Australia.
Andre M De WolfDepartment of Anesthesiology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Jan F A HendrickxDepartment of Anesthesiology, Intensive Care and Pain Therapy, OLV Hospital, Aalst, Belgium. jcnwahendrickx@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current hypoxic guards systems fail to maintain the inspired O2 concentration (FIO2) ≥ 21 % across the entire fresh gas flow (FGF) range when a second carrier gas is used (N2O or air). We examined the performance of the Maquet O2 Guard(®), a smart hypoxic guard that increases O2 delivery if an inspired hypoxic mixture is formed. After obtaining IRB approval and informed consent, 12 ASA I-II patients were enrolled. During anesthesia with sevoflurane in O2/air, the O2 Guard(®) was tested by administering O2/air at the following delivered hypoxic guard limits [expressed as (total FGF in L min(-1); FDO2 in %)] for 4 min each: [0.3;67], [0.4;50], [0.6;34], [0.8;25], [1.0;21], [1.2;21], [1.5;21], [2;21], [3;21], and [5;21]. The following data were collected: (1) time from FIO2 = 30 to 20 %; (2) time from FIO2 = 20 % to O2 Guard(®) activation; (3) time from O2 Guard(®) activation to FIO2 = 25 %; (4) FGF and FDO2 used by the O2 Guard. If SpO2 was <90 % for 10 s or longer at any time, the patient was excluded. Three patients were excluded for low SpO2. The incidence of FIO2 < 21 % was 100 % within the 1-2 L min(-1) FGF range. The O2 Guard(®) was activated within 20 s after FIO2 became 20 %, except in one patient where FIO2 oscillated between 20 and 21 %. FDO2 was increased to 60 % and FGF to 1 L min(-1) (the latter only if it was lower than 1 L min(-1) prior to activation of the O2 Guard). FIO2 increased to 25 % within 55 s after O2 Guard activation in all patients. The O2 Guard(®), an active inspired hypoxic guard, rapidly reverses and limits the duration of inspired hypoxic episodes when the delivered hypoxic guard fails to do so.

Indexed as

AdultAgedAged, 80 and overAnesthesia, InhalationAnesthetics, InhalationClinical AlarmsEquipment DesignEquipment Failure AnalysisFemaleHumansHypoxiaMaleMiddle AgedMonitoring, IntraoperativeNitrous OxideOxygenAnesthetics, InhalationNitrous OxideOxygenHypoxiaHypoxic guard systemHypoxic mixturesMachine standards

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.